Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T

BACKGROUND: Early identification of prognostic superior characteristics in glioma patients such as isocitrate dehydrogenase (IDH) mutation and O(6)-methylguanine-DNA-methyltransferase (MGMT) promoter methylation status is of great clinical importance. The study purpose was to investigate the non-inv...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Paech, Daniel, Windschuh, Johannes, Oberhollenzer, Johanna, Dreher, Constantin, Sahm, Felix, Meissner, Jan-Eric, Goerke, Steffen, Schuenke, Patrick, Zaiss, Moritz, Regnery, Sebastian, Bickelhaupt, Sebastian, Bäumer, Philipp, Bendszus, Martin, Wick, Wolfgang, Unterberg, Andreas, Bachert, Peter, Ladd, Mark Edward, Schlemmer, Heinz-Peter, Radbruch, Alexander
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2018
Assuntos:
Neuroimaging
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6231210/
https://ncbi.nlm.nih.gov/pubmed/29733378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy073
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares